相关实验视频
Updated: Jun 28, 2025

A Rapid In Vivo Bioassay for Developmentally Active Enhancers
突变FOXO1通过增强可访问性的增强器控制一个致癌网络
Hillary M Layden1, Jacob D Ellis1, Monica L Bomber1
1Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
这项研究揭示了突变的FOXO1转录因子驱动器如何通过改变基因可访问性来扩散大B细胞淋巴瘤 (DLBCL). mFOXO1的快速降解确定了其直接目标,这对于理解DLBCL转录失调至关重要.
科学领域:
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
- 在瘤学瘤学.
背景情况:
- 转录失调是扩散型大B细胞淋巴瘤 (DLBCL) 的一个关键特征.
- 转录调节器的突变在DLBCL中很常见,但理解它们的直接影响是具有挑战性的.
- 现有的方法缺乏时间分辨率来区分直接和间接的转录控制效应.
研究的目的:
- 开发和应用一种化学遗传方法,用于诱导转录因子FOXO1.1.的降解.
- 阐明DLBCL中突变FOXO1 (mFOXO1) 的直接标和机制.
- 研究FOXO1在维护染色质可访问性和调节DLBCL中的基因表达中的作用.
主要方法:
- 化学基因工程用于诱导FOXO1.1的降解.
- 新生转录检测用于监测基因表达动态.
- 染色体可访问性测试用于评估调节元件的活动.
- 对mFOXO1.1.的直接转录标的分析.
主要成果:
- 通过快速降解和新生的转录分析确定了mFOXO1的直接点.
- mFOXO1保持了对DLBCL至关重要的癌基因的增强剂可访问性.
- 在特定的目标基因中降解mFOXO1受损RNA聚合酶释放的降解.
- 野生类型的FOXO1表现出类似但较弱的目标调节,可以补充mFOXO1降解.
结论:
- 开发的化学遗传方法有效地分离了直接和间接的转录效应.
- 在DLBCL中,mFOXO1在通过增强剂调节来维持瘤基因表达方面发挥着关键作用.
- 向FOXO1功能代表了DLBCL的潜在治疗策略.
更多相关视频
11:36Author Spotlight: An Integrated Workflow to Study the Promoter-Centric Spatio-Temporal Genome Architecture in Scarce Cell Populations
Published on: April 21, 2023
09:58Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
相关概念视频
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Epigenetic Regulation
X-chromosome...
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Regulation of Expression at Multiple Steps
Induced Pluripotent Stem Cells
Somatic...